ahlam1399
05-31-2015, 01:07 AM
UPDATE 1-Pfizer?s Ibrance drug slows progression of breast cancer
CHICAGO May 30 (Reuters) - A Phase III trial of Pfizer Inc's Ibrance showed that, in combination with hormonetherapy, the drug more than doubled the duration of diseasecontrol for women with the...http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=shmPeSKZgbE:Jk_fb7wXMPo:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=shmPeSKZgbE:Jk_fb7wXMPo:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=shmPeSKZgbE:Jk_fb7wXMPo:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=shmPeSKZgbE:Jk_fb7wXMPo:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=shmPeSKZgbE:Jk_fb7wXMPo:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/shmPeSKZgbE
CHICAGO May 30 (Reuters) - A Phase III trial of Pfizer Inc's Ibrance showed that, in combination with hormonetherapy, the drug more than doubled the duration of diseasecontrol for women with the...http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=shmPeSKZgbE:Jk_fb7wXMPo:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=shmPeSKZgbE:Jk_fb7wXMPo:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=shmPeSKZgbE:Jk_fb7wXMPo:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=shmPeSKZgbE:Jk_fb7wXMPo:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=shmPeSKZgbE:Jk_fb7wXMPo:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/shmPeSKZgbE